Please make a tax deductible donation at this LINK. 

IPD Translational Investigator Dr. Ingrid Swanson Pultz was awarded a Matching Grant award of $250K from the Life Sciences Discovery Fund (LSDF) for her project ‘In vivo assessment of an oral therapeutic for celiac disease‘!

We need to raise an additional $74K to make the full match.

Learn more about this project by watching this short  video.

For more information, watch this longer WBBA video, interview with Ingrid, and look this slide presentation.

The goal of this LSDF funded research is to assess the efficacy, safety, and optimal dosing of KumaMax and its variants as an oral enzyme therapy for celiac disease.

KumaMax is the winner of the 2013 Innovation Award at the UW.   KumaMax is a computationally designed enzyme which efficiently breaks down gluten in the stomach before it reaches the small intestine where it can cause inflammation in celiac disease patients.

The LSDF Matching Grant has the requirement that the UW must raise an additional 1:1 match of $250K to support this innovative project.

We need your support !  The Institute for Protein Design has received $176K in matching funds from generous philanthropists to support this work.

Every $ counts.  We thank everyone for their generous support.